Active Ingredient: TAZAROTENE
Proprietary Name: TAZAROTENE
Dosage Form; Route of Administration: GEL; TOPICAL
Strength: 0.05%
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213079
Product Number: 001
Approval Date: Apr 25, 2023
Applicant Holder Full Name: PADAGIS ISRAEL PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information